Clinical Study of Active Intervention in High-risk HFpEF Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

924

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2028

Conditions
Heart Failure With Preserved Ejection Fraction
Interventions
OTHER

Targeted intervention based on risk factors

Correct hypoalbuminemia, anemia or hyponatremia, and try to enhance medication to lower NT-proBNP, CRP, NYHA Classification, to add diuretics for patients with higher RADs, multidiscipline intervention for patients complicating COPD, and actively reperfusion for ischemic HFpEF patients.

All Listed Sponsors
collaborator

The First People's Hospital of Xiangtan City

UNKNOWN

collaborator

The Xiangtan People's Hospital

UNKNOWN

collaborator

The Xiangxiang People's Hospital

UNKNOWN

lead

Xiangtan Central Hospital

OTHER

NCT06532019 - Clinical Study of Active Intervention in High-risk HFpEF Patients | Biotech Hunter | Biotech Hunter